Skip Navigation

Profile

Anthony J. Bleyer, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

84 Ratings
18 Comments
 

Anthony J. Bleyer, M.D.

Professor,

Clinical Interests

Diabetic Kidney Disease, Peritoneal Dialysis, New treatments for kidney disease, Epidemiology of kidney disease, Hemodialysis, Kidney Diseases (Inherited)

Contact Information

Returning Patient Appointments: 336-716-4650
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • B.S., Rensselaer PolyTechnical Institute, 1982
  • M.D., Baylor College of Medicine, 1987
  • Internship, Internal Medicine, Johns Hopkins Affil Hosps, 1988
  • Residency, Internal Medicine, Johns Hopkins Affil Hosps, 1990
  • Fellowship, Univ of Pa School of Medicine, 1992

Board Certifications

  • American Board of Internal Medicine, Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Int'L Society Peritoneal Dialy
  • Nat'L Kidney Foundation
  • Am Soc Of Nephrology

NPI Number

  • 1346225778
Anthony J. Bleyer, M.D.

Doctor Rating

4.8 out of 5

84 Ratings
18 Comments
 

Anthony J. Bleyer, M.D.

Professor, Nephrology

Research Interests

Kidney Failure, Chronic; Renal Dialysis; Kidney Diseases; Nephrology; Mucoproteins
More »

Contact Information

Academic: 336-716-4650 | Department: 336-716-4650

Recent Publications

Autosomal dominant tubulointerstitial kidney disease due to MUC1 mutation. Yu SM, Bleyer AJ, Anis K, Herlitz L, Zivna M, Hulkova H, Markowitz GS, Jim B.. Am J Kidney Dis. 2018;71(4):495-500.

Identification of a novel UMOD mutation (c.163G greater than A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease. Lopes LB, Abreu CC, Souza CF, Guimaraes LER, Silva AA, Aguiar-Alves F, Kidd KO, Kmoch S, Bleyer AJ, Almeida JR.. Braz J Med Biol Res. 2018;51(3):e6560.

3D computed tomography angiography as a novel post-processing approach in diagnosis of pediatric malignant bone tumors. Wu J, Wang C, Li M, Luo C, Liu X, Xie L, He L, Gong M, Hu Z, Bleyer AJ, Zhang Y.. J Xray Sci Technol. 2018;26(1):147-154.

3D reconstruction images of cone beam computed tomography applied to maxillofacial fractures: a case study and mini review. Bai L, Li L, Su K, Bleyer A, Zhang Y, Ji P.. J Xray Sci Technol. 2018;26(1):115-123.

Indiscriminate use of hypothermia could be deleterious in heart failure patients with cardiac arrest [abstract]. Dutta A, Azizian J, Masmoudi Y, McDonald M, Bleyer A, Jogu HR, Patel N, McLean A, Gaddam A, Qureshi W.. J Am Coll Cardiol. 2018;71(11 Suppl):736.

Noninvasive immunohistochemical diagnosis and novel MUC1 mutations causing autosomal dominant tubulointerstitial kidney disease. Zivna M, Kidd K, Pristoupilova A, Baresova V, DeFelice M, Blumenstiel B, Harden M, Conlon P, Lavin P, Connaughton DM, Hartmannova H, Hodanova K, Stranecky V, Vrbacka A, Vyletal P, Zivny J, Votruba M, Sovova J, Hulkova H, Robins V, Perry R, Wenzel A,.. J Am Soc Nephrol. 2018;():.

Sickle cell trait and interpretation of hemoglobin A1c levels [editorial]. Bleyer AJ, Aloi JA.. JAMA. 2017;317(5):481-482.

Autosomal dominant tubulointerstitial kidney disease. Bleyer AJ, Kidd K, Zivna M, Kmoch S.. Adv Chronic Kidney Dis. 2017;24(2):86-93.

Urine-derived stem cells: a potential bio-marker for renal insufficiency [abstract]. Dou L, Xiong G, Zhang D, Tang W, Yi H, Li G, Bleyer M, Bleyer A, Atala A, Takahashi Y, Ma J, Zhang Y.. Tissue Eng Part A. 2017;23(Suppl 1):S81.

Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease. Kim Y, Park SJ, Manson SR, Molina CA, Kidd K, Thiessen-Philbrook H, Perry RJ, Liapis H, Kmoch S, Parikh CR, Bleyer AJ, Chen YM.. JCI Insight. 2017;2(23):e92896.

Tamm Horsfall glycoprotein and uromodulin: it is all about the tubules! [editorial]. Bleyer AJ, Kmoch S.. Clin J Am Soc Nephrol. 2016;11(1):6-8.

Development and validation of a mass spectrometry-based assay for the molecular diagnosis of mucin-1 kidney disease. Blumenstiel B, DeFelice M, Birsoy O, Bleyer AJ, Kmoch S, Carter TA, Gnirke A, Kidd K, Rehm HL, Ronco L, Lander ES, Gabriel S, Lennon NJ.. J Mol Diagn. 2016;18(4):566-571.

Acadian variant of Fanconi Syndrome is caused by mitochondrial respiratory chain complex I deficiency due to a non-coding mutation in complex I assembly factor NDUFAF6. Hartmannova H, Piherova L, Tauchmannova K, Kidd K, Acott PD, Crocker JF, Oussedik Y, Mallet M, Hodanova K, Stranecky V, Pristoupilova A, Baresova V, Jedlickova I, Zivna M, Sovova J, Hulkova H, Robins V, Vrbacky M, Pecina P, Kaplanova V, Houstek J,.. Hum Mol Genet. 2016;25(18):4062-4079.

Heterozygous loss-of-function SEC61A1 mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia. Bolar NA, Golzio C, Zivna M, Hayot G, Van Hemelrijk C, Schepers D, Vandeweyer G, Hoischen A, Huyghe JR, Raes A, Matthys E, Sys E, Azou M, Gubler MC, Praet M, Van Camp G, McFadden K, Pediaditakis I, Pristoupilova A, Hodanova K, Vylet'al, P,.. Am J Hum Genet. 2016;99(1):174-187.

Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report. Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O.. Kidney Int. 2015;88(4):676-683.

Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis. Bleyer AJ, Wright D, Alcorn H.. Clin Nephrol. 2015;83(5):286-292.

Climate temperature affects the age of onset of end stage renal disease [abstract]. Bleyer ME, Abbas MM, Swain E, Kidd KO, Bleyer AJ.. J Am Soc Nephrol. 2015;26(Abstract Suppl):208A.

Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A,.. Clin J Am Soc Nephrol. 2014;9(3):527-535.

Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Murea M, James KM, Russell GB, Byrum GV III, Yates JE, Tuttle NS, Bleyer AJ, Burkart JM, Freedman BI.. Clin J Am Soc Nephrol. 2014;9(4):764-770.

Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ.. JAMA Intern Med. 2014;174(9):1442-1449.

Autosomal dominant tubulointerstitial kidney disease: of names and genes [editorial commentary]. Bleyer AJ, Kmoch S.. Kidney Int. 2014;86(3):459-461.

A population-based study of the U.S. population shows the majority of persons cannot donate due to preventable diseases and socio-economic conditions [abstract]. Bleyer AJ, Reeves-Daniel AM.. J Am Soc Nephrol. 2014;25(Abstract Suppl):67A.

Comparison of age of onset of end-stage kidney disease in medullary cystic kidney disease types 1 and 2 [abstract]. Abbas MM, Kidd KO, Kmoch S, Bleyer AJ.. J Am Soc Nephrol. 2014;25(Abstract Suppl):771A.

Broadening the differential of cystic kidney disease: disease [abstract]. Corapi KM, McGrath MM, Bleyer AJ, Greka A.. J Am Soc Nephrol. 2014;25(Abstract Suppl):423A.

Uromodulin (UMOD) gene polymorphism shows different associations with chronic kidney disease in Euro-American versus African-American individuals with diabetes mellitus [abstract]. Bleyer AJ, Kmoch S, Langefeld CD, Raffield LM, Lu L, Bowden DW, Freedman BI.. J Am Soc Nephrol. 2014;25(Abstract Suppl):418A.

Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, Hulkova H, Sovova J, Vylet'al P, Antignac C, Guttman M, Handsaker RE,.. Nat Genet. 2013;45(3):299-303.

Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study. Gunzler D, Bleyer AJ, Thomas RL, O Brien A, Russell GB, Sattar A, Iyengar SK, Thomas C, Sedor JR, Schelling JR.. BMC Nephrol. 2013;14():124.

Clinical implications of the relationship between low calcium concentration dialysate and sudden death [editorial]. Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(5):706-707.

American Society of Nephrology quiz and questionnaire 2012: electrolytes. Palmer BF, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(6):1048-1053.

American Society of Nephrology quiz and questionnaire 2012: transplantation. Brennan DC, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(7):1267-1272.

American society of nephrology quiz and questionnaire 2012: glomerulonephritis. Fervenza FC, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(8):1460-1465.

American society of nephrology quiz and questionnaire 2012: renal replacement therapy. Mehrotra R, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2013;8(9):1632-1636.

Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K.. Ann Intern Med. 2013;159(4):233-242.

Kidney transplant exposing central diabetes insipidus [abstract]. Robinson TW, Bleyer AJ.. J Am Soc Nephrol. 2013;24(Abstract Suppl):288A.

Variable clinical presentation in individuals with a MUC1 mutation causing medullary cystic kidney disease type 1 [abstract]. Bleyer AJ, Kmoch S, Kidd KO, Robins VC, Hodanova K.. J Am Soc Nephrol. 2013;24(Abstract Suppl):304A.

Risk of catheter-related bloodstream infections in elderly patients on hemodialysis [abstract]. Murea M, James KM, Russell GB, Bleyer AJ, Burkart JM, Freedman BI.. J Am Soc Nephrol. 2013;24(Abstract Suppl):396A.

Pegloticase, a recombinant uricase for the treatment of advanced gout, maintains therapeutic concentrations during dialysis [abstract]. Bleyer AJ, Wright DE, Glicklich A.. J Am Soc Nephrol. 2013;24(Abstract Suppl):461A.

Renin gene mutation causing anemia and kidney injury in childhood [abstract]. Hashim FQ, Bleyer AJ, Kmoch S, Neiberger RE.. J Am Soc Nephrol. 2013;24(Abstract Suppl):608A.

Implications of an unusual diagnosis: uromodulin-associated kidney disease [abstract]. Bolanos JA, Bleyer AJ, Yuan CM, Thurlow JS.. J Am Soc Nephrol. 2013;24(Abstract Suppl):608A.

The use of a U.S. veterans' chronic kidney disease database to model the SPRINT (Systolic Blood Pressure Intervention) Trial [abstract]. Bleyer AJ, Lu JL, Molnar MZ, Ma JZ, Canada RB, Kalantar-Zadeh K, Kovesdy CP.. J Am Soc Nephrol. 2013;24(Abstract Suppl):680A-681A.

Mutations in a large VNTR of MUC1 are frequent in autosomal dominant medullary cystic kidney disease (MCKD) [abstract]. Moriniere V, Hollebecque S, Lebbah S, Megarbane A, Gnirke A, Blumenstiel B, Bleyer AJ, Kirby A, Knebelmann B, Antignac C.. J Am Soc Nephrol. 2013;24(Abstract Suppl):68A.

Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis [abstract]. Bleyer AJ, Wright DE, Glicklich A.. Arthritis Rheum. 2013;65(Suppl 10):S497-S498.

Medullary cystic kidney disease type 1. Bleyer AJ, Kmoch S. In: Pagon RA, Adam MP Ardinger HH, et al, eds. GeneReviews [internet]. Seattle (WA);2013: .

Nephrology quiz and questionnaire: electrolytes. Palmer BF, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2012;7(6):1047-1052.

Cardiovascular disease: modifiable risk factors for sudden death in dialysis patients. Bleyer AJ, Hawfield A.. Nat Rev Nephrol. 2012;8(6):323-324.

Nephrology quiz and questionnaire: transplantation. Hricik DE, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2012;7(7):1190-1194.

Nephrology quiz and questionnaire: renal replacement therapy. Golper TA, Glassock RJ, Bleyer AJ.. Clin J Am Soc Nephrol. 2012;7(8):1347-1352.

Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Murea M, Moran T, Russell GB, Shihabi ZK, Byers JR, Andries L, Bleyer AJ, Freedman BI.. Am J Nephrol. 2012;36(5):488-496.

Gout: a step forward [editorial]. Bleyer AJ, Kmoch S.. Adv Chronic Kidney Dis. 2012;19(6):356-357.

Changes in serum urate and urate excretion with age. Stiburkova B, Bleyer AJ.. Adv Chronic Kidney Dis. 2012;19(6):372-376.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Diabetic Kidney Disease, Peritoneal Dialysis, New treatments for kidney disease, Epidemiology of kidney disease, Hemodialysis, Kidney Diseases (Inherited)
Anthony J. Bleyer, M.D.

Anthony J. Bleyer, M.D.

Professor, Nephrology

Doctor Rating

4.8 out of 5

Anthony J. Bleyer, M.D.84 Ratings
18 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.9
Time CP spent with patient
4.9
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

6/18/2018

I highly recommend Dr. Bleyer,he has helped me in many ways,is very concerned...wonderful doctor...

6/2/2018

Dr Bleyer is the the best! He listens to all my concerns and explains things in a way I can understand. I am so fortunate to have him as my doctor. I value his opinion on any of my kidney or other medical issues.

4/24/2018

Dr. Bleyer is truly one of the best. He provides excellent medical care.

4/23/2018

I am fairly new to Dr. Bleyer and this is my second hospital clinic visit where I got to set down face to face. I have been quite nervous because of what PD told him about me. But I am a very complient patient and do all I can with what I have available to me.He is very knowlegdable andcaring with good bed side manner . Traits I admire and require in a specialist of this nature. I wasn't sure I could ever find one like Dr. Satko but given time I think this could grow into ax very good and lasting relationship.

3/29/2018

dr. Bleyer is the best nephrologist I've ever had. he takes the time either through mywakehealth or over the phone or in clinic

3/28/2018

dr.bleyer is the best physician i've ever been to.

3/26/2018

Dr Bleyer has goes above and beyond to include my family in my care under him as my first visit he was nice enough to include them in the visit via fb msgr chat. Not many doctors do that, was nice to feel them close and included.

3/8/2018

Dr. Bleyer is and always has been well informed regarding my condition and treatment . He always goes over my labs, meds, and any problems or concerns which may arise.

2/7/2018

*Dr. Bleyer is the best physician that I've ever had. He is excellent!

12/20/2017

*Dr. Bleyer is a very caring, professional and great doctor. I could not ask for a better nephrologist. I really value his medical opinion.

12/1/2017

*Dr Bleyer is the best provider I have seen. He is very knowledgeable of my condition and communicates promptly by "MyChart."

10/31/2017

*Dr. Bleyer always has my best interest at _____ and he truly cares about his patients. I am a difficult _____ and I always trust his advice and opinion. He is an excellent doctor. I am so fortunate to have him as my nephrologist.

10/30/2017

Dr. Bleyer is an excellent nephrologist. He knows my kidney and complicated medical history and always has my best interest at heart. I trust his opinion and advice.

9/26/2017

*Dr. Bleyer saved my life.

9/22/2017

*Dr. Bleyer is awesome! I trust his expectations advice with my kidney transplant & health. I feel EXTREMELY LUCKY to have him as my doctor. He knows my medical history like know other doctor, and always has my best interest in mind, very thankful for him.

9/8/2017

He even suggested a few local restaurants; very personable!

8/26/2017

Dr. Bleyer is an excellent doctor! He is my doctor, as well as my daughter's doctor. He is very caring, thorough and personable.I feel very fortunate to have him as my doctor.

8/15/2017

Dr. Bleyer is simply one of best in terms of knowledge, patient care and respect.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  26 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.